{"id":36026,"date":"2015-05-12T11:57:08","date_gmt":"2015-05-12T15:57:08","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36026"},"modified":"2015-05-12T11:57:08","modified_gmt":"2015-05-12T15:57:08","slug":"plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026","title":{"rendered":"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) <\/strong>is one of the leading biopharmaceutical companies in the country with a primary focus on gene therapy and advancing cell therapy. As per the <a href=\"http:\/\/www.marketwatch.com\/story\/plasmatech-biopharmaceuticals-closes-10-million-financing-2015-05-11-141735148\">reports<\/a>, the company has closed an equity funding worth as much as $10 million at $8 per share for 125,000 shares and warrants to buy 625,000 shares of common stock.<\/p>\n<p style=\"text-align: justify;\"><strong>How Lucrative The Deal Is:<\/strong><\/p>\n<p style=\"text-align: justify;\">All the warrants can be exercised at $10 per share for maximum 30 months from the date of closing the transaction. The company plans to use the proceeds for providing support to the continued development of various programs run by the company in orphan diseases. Other objectives include working capital requirements, general corporate purposes, expansion of the portfolio in various rare disease programs, etc.<\/p>\n<p style=\"text-align: justify;\">The senior leadership team of the company is delighted to have received this financing. According to Steven H. Rouhandeh, Executive Chairman, Plasmatech, support given to the company shows the trust of the investment community on Plasmatech and its professional objectives. The company has been trying very hard to be a leader in the rare disease therapies for months now. In order to enhance its expertise in the same field, Plasmatech acquired Abeona Therapeutics in the last week. It had entered into an agreement with Abeona Therapeutics to buy it for an undisclosed amount.<\/p>\n<p style=\"text-align: justify;\">Apart from this acquisition, the company is also focusing on various programs in Sanfilippo Syndrome to get more clarity about this field than before. Rouhandeh clarified that the recent financing worth $10 million was not necessary to execute the acquisition transaction. Plasmatech would utilize this money in manufacturing of clinical material, the in-licensing of synergistic and complementary programs in gene and cell therapies and expansion the efforts to identify orphan proteins.<\/p>\n<p style=\"text-align: justify;\">Rouhandeh anticipates that coming few months will be critical for the company, and the management team will need to put 100% efforts to get things done in an effective way<strong>.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) is one of the leading biopharmaceutical companies in the country with a primary focus on gene therapy and advancing cell therapy. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":32925,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[11405,11404,11484],"stock_ticker":[],"class_list":["post-36026","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqptbi","tag-plasmatech-biopharmaceuticals-inc-nasdaqptbi","tag-steven-h-rouhandeh","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) is one of the leading biopharmaceutical companies in the country with a primary focus on gene therapy and advancing cell therapy. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-05-12T15:57:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing\",\"datePublished\":\"2015-05-12T15:57:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026\"},\"wordCount\":322,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"keywords\":[\"NASDAQ:PTBI\",\"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI)\",\"Steven H. Rouhandeh\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026\",\"name\":\"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"datePublished\":\"2015-05-12T15:57:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026","og_locale":"en_US","og_type":"article","og_title":"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing - Wall Street PR","og_description":"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) is one of the leading biopharmaceutical companies in the country with a primary focus on gene therapy and advancing cell therapy. [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-05-12T15:57:08+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing","datePublished":"2015-05-12T15:57:08+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026"},"wordCount":322,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","keywords":["NASDAQ:PTBI","Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI)","Steven H. Rouhandeh"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026","url":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026","name":"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","datePublished":"2015-05-12T15:57:08+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/plasmatech-biopharmaceuticals-inc-nasdaqptbi-raises-10-million-financing-36026#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) Raises $10 Million Financing"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36026"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36026\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/32925"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36026"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}